BiotechTubeBiotechTube
Home/Pipeline/ASP1929

ASP1929

Solid Tumors

Phase 2Active

Key Facts

Indication
Solid Tumors
Phase
Phase 2
Status
Active
Company
Astellas Pharma

About Astellas Pharma

Astellas Pharma Inc. is one of Japan's leading pharmaceutical companies with a global presence, dedicated to turning innovative science into value for patients. The company has built a strong portfolio of prescription medicines and is advancing multiple programs through clinical development, with particular expertise in urology, oncology, immunology, and neuroscience. Astellas is committed to becoming a global biopharmaceutical company by leveraging external innovation and strategic partnerships.

View full company profile

Therapeutic Areas

UrologyOncologyImmunologyNeuroscienceNephrology

Other Solid Tumors Drugs

DrugCompanyPhase
GSK4362676GSK plcPhase 1
ABBV-154AbbViePhase 1
TAK-981Takeda PharmaceuticalPhase 1/2
TAK-676Takeda PharmaceuticalPhase 1
TAK-573Takeda PharmaceuticalPhase 1
TAK-164Takeda PharmaceuticalPhase 1
SHR-1316Jiangsu Hengrui MedicinePhase 1/2
BAY 2927088BayerPhase 1
IBI188Innovent BiologicsPhase 1
Bispecific AntibodyAkesoPhase 1/2
CSPC-DM02CSPC Pharmaceutical Group LimitedPhase 2
ONO-4538 combinationsOno PharmaceuticalPhase 2